Tender opportunity published by Southern Health and Social Care Trust on TenderSignal, the UK public sector tender monitoring platform.
An approved treatment as an adjunct to diet and other low-density lipoprotein-cholesterol (LDL-C) lowering therapies for the treatment of adult and paediatric patients aged 6 months and older with homozygous familial hypercholesterolaemia (HoFH).